Mr. Porter serves as our Vice President of Regulatory Affairs.  He has over 20 years of experience in the pharmaceutical and biotechnology industry.  He is a California licensed attorney with an M.B.A. and J.D. from the University of Kansas.  Prior to joining Viking, he was the Executive Director of Regulatory Affairs at Protagonist Therapeutics, where he was responsible for developing and executing the company’s regulatory strategy and preparing the company to file its first new drug application (NDA).   Prior to Protagonist, he has been the regulatory lead for programs at Pfizer, Arena Pharmaceuticals, Janssen Research and Development, and Inovio Biomedical.  He was instrumental in filing and obtaining FDA approval for multiple new drugs at Janssen, including the first-in-class diabetes drug Invokana (canagliflozin) and two fixed dose combinations with canagliflozin and metformin (Invokamet and Invokamet XR).  His experience includes small molecules, peptides, and biologics and all phases of clinical development.